Literature DB >> 33568498

Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors.

Chunlong Ma1, Jun Wang2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33568498     DOI： 10.1073/pnas.2024420118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  21 in total

Review 1.  Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines.

Authors:  Queenie Fernandes; Varghese Philipose Inchakalody; Maysaloun Merhi; Sarra Mestiri; Nassiba Taib; Dina Moustafa Abo El-Ella; Takwa Bedhiafi; Afsheen Raza; Lobna Al-Zaidan; Mona O Mohsen; Mariam Ali Yousuf Al-Nesf; Ali Ait Hssain; Hadi Mohamad Yassine; Martin F Bachmann; Shahab Uddin; Said Dermime
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

2.  Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitor.

Authors:  Haozhou Tan; Chunlong Ma; Jun Wang
Journal:  Res Sq       Date:  2022-03-30

3.  Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir.

Authors:  Zilei Xia; Michael Sacco; Yanmei Hu; Chunlong Ma; Xiangzhi Meng; Fushun Zhang; Tommy Szeto; Yan Xiang; Yu Chen; Jun Wang
Journal:  ACS Pharmacol Transl Sci       Date:  2021-06-09

4.  Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses.

Authors:  Yanmei Hu; Chunlong Ma; Tommy Szeto; Brett Hurst; Bart Tarbet; Jun Wang
Journal:  ACS Infect Dis       Date:  2021-03-01       Impact factor: 5.578

5.  Discovery of Potent and Broad-Spectrum Pyrazolopyridine-Containing Antivirals against Enteroviruses D68, A71, and Coxsackievirus B3 by Targeting the Viral 2C Protein.

Authors:  Yanmei Hu; Naoya Kitamura; Rami Musharrafieh; Jun Wang
Journal:  J Med Chem       Date:  2021-06-04       Impact factor: 8.039

6.  Discovery of SARS-CoV-2 papain-like protease inhibitors through a combination of high-throughput screening and FlipGFP-based reporter assay.

Authors:  Zilei Xia; Michael Dominic Sacco; Chunlong Ma; Julia Alma Townsend; Naoya Kitamura; Yanmei Hu; Mandy Ba; Tommy Szeto; Xiujun Zhang; Xiangzhi Meng; Fushun Zhang; Yan Xiang; Michael Thomas Marty; Yu Chen; Jun Wang
Journal:  bioRxiv       Date:  2021-03-16

Review 7.  A Review of the Current Landscape of SARS-CoV-2 Main Protease Inhibitors: Have We Hit the Bullseye Yet?

Authors:  Guillem Macip; Pol Garcia-Segura; Júlia Mestres-Truyol; Bryan Saldivar-Espinoza; Gerard Pujadas; Santiago Garcia-Vallvé
Journal:  Int J Mol Sci       Date:  2021-12-27       Impact factor: 5.923

8.  Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay.

Authors:  Chunlong Ma; Michael Dominic Sacco; Zilei Xia; George Lambrinidis; Julia Alma Townsend; Yanmei Hu; Xiangzhi Meng; Tommy Szeto; Mandy Ba; Xiujun Zhang; Maura Gongora; Fushun Zhang; Michael Thomas Marty; Yan Xiang; Antonios Kolocouris; Yu Chen; Jun Wang
Journal:  ACS Cent Sci       Date:  2021-06-18       Impact factor: 14.553

9.  Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2.

Authors:  Mohammad Afsar; Rohan Narayan; Md Noor Akhtar; Deepakash Das; Huma Rahil; Santhosh Kambaiah Nagaraj; Sandeep M Eswarappa; Shashank Tripathi; Tanweer Hussain
Journal:  Elife       Date:  2022-03-24       Impact factor: 8.713

10.  Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo.

Authors:  Otávio Augusto Chaves; Carolina Q Sacramento; André C Ferreira; Mayara Mattos; Natalia Fintelman-Rodrigues; Jairo R Temerozo; Leonardo Vazquez; Douglas Pereira Pinto; Gabriel P E da Silveira; Laís Bastos da Fonseca; Heliana Martins Pereira; Aluana Santana Carlos; Joana C d'Avila; João P B Viola; Robson Q Monteiro; Patrícia T Bozza; Hugo Caire Castro-Faria-Neto; Thiago Moreno L Souza
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.